Table 3.
Antibiotic non-susceptibilities* of the most frequently uropathogens isolated at the initial and the recurrent UTI episodes.
| Antibiotic | Organism |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
E. coli n (%) |
Klebsiella spp. n (%) |
M. morganii n (%) |
Proteus spp. n (%) |
Enterobacter spp. n (%) |
Enterococcus spp. n (%) |
|||||||
| UTI episode timing |
||||||||||||
| I** n = 95 |
II** n = 12 |
I n = 21 |
II n = 2 |
I n = 11 |
II n = 0 |
I n = 11 |
II n = 1 |
I n = 8 |
II n = 2 |
I n = 14 |
II n = 1 |
|
| Ampicillin | 55/95 (57.9) | 7/12 (58.3) | 18/20 (90) | 2/2 (100) | 11/11 (100) | 7/11 (63.6) | 2/2 (100) | 7/8 (87.5) | 2/2 (100) | 0/13 | 1/1 (100) | |
| TMP/SMX | 7/71 (9.9) | 0/10 | 1/16 (6.3) | 0/2 | 2/8 (25) | 0/5 | 1/1 (100) | 0/6 | – | 2/10 (20) | – | |
| Cefuroxime | 5/92 (5.4) | 0/10 | 3/21 (14.3) | 1/2 (50) | 1/10 (10) | 0/11 | 0/1 | 1/7 (14.3) | 2/2 (100) | 3/10 (30) | – | |
| Ceftriaxone | 3/77 (3.9) | 2/12 (100) | 1/16 (6.3) | 0/1 | 2/9 (22.2) | 1/11 (9.1) | – | 0/7 | 2/2 (100) | 3/8 (37.5) | – | |
| Gentamicin | 2/94 (2.1) | 0/12 | 1/21 (4.8) | – | 3/11 (27.3) | 0/11 | 0/1 | 0/8 | 0/2 | 2/13 (15.4) | 0/1 | |
| Amoxicillin/clavulanic acid | 5/37 (13.5) | 4/5 (80) | 3/14 (21.4) | – | 1/4 (25) | 4/9 (44.4) | – | 1/1 (100) | 1/1 (100) | 3/7 (42.9) | – | |
| Ciprofloxacin | 3/29 (10.3) | 0/1 | 2/5 (40) | – | 1/3 (33.3) | 2/5 (40) | – | 0/1 | – | 6/7 (85.7) | – | |
*
Antibiotic susceptibilities for some antibiotic drugs not determined for all pathogens.
**
I, initial UTI episode; II, recurrent UTI episode.
TMP/SMX, trimethoprim/sulfamethoxazole.